DOCSLIB.ORG

Escos 02.12.2011

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Escos 02.12.2011 ESCOS EHEALTH SEMANTIC AND CONTENT FOR SWITZERLAND 02.12.2011 CORRESPONDENCE Dr. Reinhold Sojer Prof. Henning Müller [email protected] [email protected] BlueCare AG HES‐SO Pflanzschulstrasse 3 TechnoArk 3 8400 Winterthur 3960 Sierre Dr. Dominik Aronsky Prof. Patrick Ruch [email protected] [email protected] II4SM AG HES‐SO Genève Bollwerk‐Promenade 5 7 route de Drize 4051 Basel 1227 Genève ACKNOWLEDGEMENTS We would like to thank the following people for their support: Judith Wagner, Prof. Claire‐Anne Siegrist, Stefan Wyss, Adrian Schmidt, Prof. Christian Lovis, Christian Hay, Tony Schaller, Philippe Schaller, Stéphane Spahni, Arnaud Gaudinat, Alain Périé, Karima Bourcquart, Eric Poiseau, Anne‐Gaëlle Berge, Anni Buhr, Christine Roth, Marcello Melgara, Stefan Schulz, Alberto Guardia. Die Analysen, Vorschläge und Empfehlungen in diesem Dokument sind das Resultat der Konzept- arbeiten des Mandatnehmers im Dialog mit der Co-Leitung des Teilprojekts „Standards und Architektur“. Sie richten sich an die Gremien von „eHealth Suisse“ und dienen dort als Grundlage für die Diskussion im Hinblick auf die Verabschiedung von weiteren Empfehlungen. Diese Vorschläge können von den konsolidierten und verabschiedeten Empfehlungen von „eHealth Suisse“ abweichen. 2 Table of Contents 1 Executive Summary ......................................................................................................................... 5 2 Introduction ..................................................................................................................................... 8 3 Basic Concepts and overview .......................................................................................................... 9 3.1 Definitions ............................................................................................................................... 9 3.2 Semantic Interoperability of Medical Content ...................................................................... 10 3.3 International Trends in Semantic Interoperability ................................................................ 13 3.3.1 Primary standard development efforts ......................................................................... 14 3.3.2 Other interest groups .................................................................................................... 17 3.3.3 Situation in Nordic countries ......................................................................................... 18 3.4 epSOS ..................................................................................................................................... 19 4 Situation and Requirements in Switzerland .................................................................................. 24 4.1 Selection of Current Projects ................................................................................................. 24 4.2 Terminological Landscape ..................................................................................................... 26 4.3 Locally Developed Standards ................................................................................................ 31 4.3.1 CHOP .............................................................................................................................. 31 4.3.2 Swiss Medical Exchange (SMEEX) Initiative ................................................................... 31 4.3.3 Swiss Medical Reference System (SMERF) .................................................................... 32 4.4 Positioning of Switzerland within the International Community .......................................... 33 4.5 Terminological Standards for the Encoding of Procedures ................................................... 35 5 Results and Discussion .................................................................................................................. 39 5.1 Quantitative Benchmarking of Terminologies and Information Models .............................. 39 5.1.1 Terminologies ................................................................................................................ 39 5.1.2 Description and Motivation of complex assessment criteria ........................................ 41 5.1.3 Clinical Information Models .......................................................................................... 43 5.2 Terminologies ........................................................................................................................ 48 5.2.1 SNOMED ........................................................................................................................ 48 5.2.2 LOINC ............................................................................................................................. 49 5.2.3 ICD10 ............................................................................................................................. 49 5.2.4 Alpha‐ID ......................................................................................................................... 49 5.2.5 ATC ................................................................................................................................. 50 5.2.6 SMERF ............................................................................................................................ 50 5.2.7 Tentative Conclusion ..................................................................................................... 51 5.3 Information Models ............................................................................................................... 51 3 5.3.1 CDA R2 ........................................................................................................................... 51 5.3.2 CCR/CCD ........................................................................................................................ 53 5.3.3 openEHR ........................................................................................................................ 53 5.3.4 DICOM ........................................................................................................................... 53 5.3.5 RadLex ........................................................................................................................... 54 5.3.6 Tentative Conclusion ..................................................................................................... 54 5.4 epSOS ..................................................................................................................................... 55 5.4.1 Evaluation ...................................................................................................................... 55 5.4.2 Tentative Recommendation regarding epSOS .............................................................. 57 5.5 Selected Use Cases ................................................................................................................ 59 5.5.1 Practical Deployment of Terminology in Healthcare .................................................... 59 5.5.2 Swiss Vaccination Record .............................................................................................. 60 5.5.3 Electronic Prescription .................................................................................................. 61 5.6 Selection and Prioritization of Information Models .............................................................. 63 5.7 Toward a Family of Swiss Terminologies ............................................................................... 63 6 Recommendation for Switzerland ................................................................................................. 67 6.1 Recommendation for Regulation (Predefinition) of Content Structures .............................. 67 6.2 Procedure ad Responsibilities ............................................................................................... 67 6.3 Licensing Aspects ................................................................................................................... 68 6.4 Implementation Plan ............................................................................................................. 70 6.5 Roadmap ............................................................................................................................... 73 7 Glossary ......................................................................................................................................... 75 8 References ..................................................................................................................................... 77 4 1 Executive Summary This report describes semantic standards and semantic interoperability in the medical field. The eHealth coordination body “eHealth Suisse” of the confederation and cantons (Koordinationsorgan eHealth Bund‐Kantone) that is responsible for the implementation of national eHealth strategy mandated this document that is being prepared by the HES‐SO (Haute Ecole Spécialisée de Suisse Occidental) and ii4sm (International Institute for the Safety of Medicines). The document starts with a short introduction to the domain of semantic interoperability to limit the vast field at least slightly, followed by an explanation of the terms employed and the main concepts used. This section is meant to explain the frequently used terms and their precise meaning as sometimes these terms are used with varying meaning. The main interest
Load more

Recommended publications
  • A Method for Constructing a New Extensible Nomenclature for Clinical Coding Practices in Sub-Saharan Africa
    MEDINFO 2017: Precision Healthcare through Informatics 965 A.V. Gundlapalli et al. (Eds.) © 2017 International Medical Informatics Association (IMIA) and IOS Press. This article is published online with Open Access by IOS Press and distributed under the terms of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0). doi:10.3233/978-1-61499-830-3-965 A Method for Constructing a New Extensible Nomenclature for Clinical Coding Practices in Sub-Saharan Africa Sven Van Laere, Marc Nyssen, Frank Verbeke Department of Public Health (GEWE), Research Group of Biostatistics and Medical Informatics (BISI), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium Abstract The word nomenclature has to be used with care in the context Clinical coding is a requirement to provide valuable data for of sub-Saharan Africa. By the word “nomenclature”, usually billing, epidemiology and health care resource allocation. In they understand: “a coding system to provide codes that are sub-Saharan Africa, we observe a growing awareness of the used in invoices, to specify the health services that were pro- need for coding of clinical data, not only in health insurances, vided for particular patients”. We define nomenclature in a but also in governments and the hospitals. Presently, coding broader way, also taking into account the clinical definition of systems in sub-Saharan Africa are often used for billing pur- health services. poses. In this paper we consider the use of a nomenclature to In this paper we will present a way to build this new nomen- also have a clinical impact.
    [Show full text]
  • Omega-3 Fatty Acids As First-Line Treatment in Paediatric Depression
    Se Clinical Study Protocol OMEGA-3 FATTY ACIDS AS FIRST-LINE TREATMENT IN PAEDIATRIC DEPRESSION. A phase III, 36-week, multi-centre, double-blind, placebo-controlled randomized superiority Study. The Omega-3-pMDD Study Study Type: Intervention with Investigational Medicinal Product (IMP) Study Categorisation: Clinical Trial with IMP Category C Study Registration: Swiss Federal Complementary Database Clinicaltrials.gov Study Identifier: SNF 33IC30_166826 Sponsor, Sponsor- Gregor Berger Investigator and Principal Investigator: Department of Child and Adolescent Psychiatry University Hospital of Psychiatry University of Zurich Neumünsterallee 9 Omega-3-pMDD, Version 3 of 13.07.2017 Page 1 of 108 CH 8032 Zürich Switzerland Phone: +41 43 499 26 71 Mobile: +41 76 464 61 54 E-Mail: [email protected] Investigational Product: Omega-3 fatty acids (1000mg EPA / 500mg DHA in > in 13 years old and 500mg EPA / 250mg DHA in < in 13 years old) Protocol Version and Version3 of 13..07.2017 Date: CONFIDENTIAL The information contained in this document is confidential and the property of the Department of Child and Adolescent Psychiatry of the University of Zurich. The information may not - in full or in part - be transmitted, reproduced, published, or disclosed to others than the applicable Independent Ethics Committee(s) and Competent Authority(ies) without prior written authorization from the Department of Child and Adolescent Psychiatry of the University of Zurich, except to the extent necessary to obtain informed consent from those participants who will participate in the study. Omega-3-pMDD, Version 3 of 13.07.2017 Page 2 of 108 SIGNATURE PAGES Study number Swiss Federal Complementary Database Study Title Omega-3 fatty acids as first-line treatment in Paediatric Depression.
    [Show full text]
  • Healthcare Terminologies and Classifications
    Healthcare Terminologies and Classifications: An Action Agenda for the United States American Medical Informatics Association and American Health Information Management Association Terminology and Classification Policy Task Force Acknowledgements AHIMA and AMIA Terminology and Classification Policy Task Force Members Keith E. Campbell, MD, PhD The American Health Chair, AHIMA and AMIA Terminologies and Classifications Policy Task Force Information Management Chief Technology Officer, Informatics, Inc., and Assistant Clinical Professor; Association (AHIMA) is the Department of Medical Informatics and Clinical Epidemiology, Oregon Health and premier association of health Science University information management Suzanne Bakken, RN, DNSc, FAAN (HIM) professionals. AHIMA’s Alumni Professor of Nursing and Professor of Biomedical Informatics School of 51,000 members are dedicated to Nursing and Department of Medical Informatics, Columbia University the effective management of personal health information Sue Bowman, RHIA, CCS needed to deliver quality Director of Coding Policy and Compliance, American Health Information healthcare to the public. Management Association Founded in 1928 to improve the quality of medical records, Christopher Chute, MD, PhD AHIMA is committed to Professor and Chair of Biomedical Informatics, Mayo Foundation advancing the HIM profession in an increasingly electronic and Don Detmer, MD, MA President and Chief Executive Officer, American Medical Informatics Association global environment through leadership in advocacy, Jennifer Hornung Garvin, PhD, RHIA, CPHQ, CCS, CTR, FAHIMA education, certification, and Medical Informatics Postdoctoral Fellow Center for Health Equity Research and lifelong learning. To learn more, Promotion, Philadelphia Veterans Administration Medical Center go to www.ahima.org. Kathy Giannangelo, MA, RHIA, CCS, CPHIMS Director, Practice Leadership, AHIMA Gail Graham, RHIA The American Medical Director, Health Data and Informatics Department of Veterans Affairs Informatics Association (AMIA) Stanley M.
    [Show full text]
  • MHSUDS Information Notice No.: 16-051
    State of California—Health and Human Services Agency Department of Health Care Services JENNIFER KENT EDMUND G. BROWN JR. DIRECTOR GOVERNOR DATE: October 7, 2016 MHSUDS INFORMATION NOTICE N O.: 16-051 TO: COUNTY BEHAVIORAL HEALTH DIRECTORS COUNTY BEHAVIORAL HEALTH DIRECTORS ASSOCIATION OF CALIFORNIA CALIFORNIA COUNCIL OF COMMUNITY BEHAVIORAL HEALTH AGENCIES CALIFORNIA ALLIANCE OF CHILD AND FAMILY SERVICES SUBJECT: IMPLEMENTATION OF THE DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS (DSM-5), FIFTH EDITION REFERENCES: MHSD INFORMATION NOTICE 13-22 MHSUDS INFORMATION NOTICE 14-040 MHSUDS INFORMATION NOTICE 15-003 MHSUDS INFORMATION NOTICE 15-030 PURPOSE The purpose of this Information Notice is to direct Mental Health Plans (MHPs) to use the American Psychiatric Association (APA) DS M-5 to make diagnostic determinations for the purposes of determining if beneficiaries meet medical necessity criteria for Medi-Cal specialty mental health services (SMHS). This Information Notice updates information previously provided in Mental Health Services Division (MHSD) Information Notice 13-22. BACKGROUND The APA issued the DSM-5 on May 20, 2013. The DSM-5 provides diagnostic criteria and codes as well as corresponding International Classification of Diseases-10 (ICD-10) codes. Since March 2013, the Department of Health Care Services (DHCS) has collaborated with internal and external stakeholders and partners to address implementation issues specific to SMHS related to the DSM-5. Mental Health & Substance Use Disorder Services 1501 Capitol Avenue, MS 4000, P.O. Box 997413 Sacramento, CA 95899-7413 Phone: (916) 440-7800 Fax: (916) 319-8219 Internet Address: www.dhcs.ca.gov MHSUDS INFORMATION NOTICE N O.: 16-051 October 7, 2016 Page 2 DHCS has issued previous MHSUDS Information Notices1 that instruct MHPs to report only ICD-10 codes for claiming and diagnoses reporting purposes and provide ICD-10 procedural and diagnosis crosswalk documents f or SMHS.
    [Show full text]
  • Health & Coding Terminological Systems
    Health & Coding Terminological Systems Hamideh Sabbaghi, MS Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran Definition of Code Code is considered as word, letter, or number which has been used as passwords instead of words or phrases. Coding System 1. Classification system 2. Nomenclature system Classification System A well-known system of corrections for naming different stages of the disease. Nomenclature System A medical list of a specific system of preferred terms for naming disease. WHO- FIC • Main/reference classification • Related classifications to the main/ reference classification • Driven classification from the main/ reference classification Main/reference classification • ICD- 10 (1990, WHA) • ICD- 11 (2007, WHO) • http://who.int/classifications/apps/icd/icd10online/ ICD with a commonest usage can be used for: • Identification of health trend, mortality and morbidity statistics. • Clinical and health research purposes. Main/reference classification • ICD-9-CM (International Classification of Diseases, Ninth Revision, Clinical Modification) • ICF (International Classification of Function, Disability and Health) • ICHI (International Classification of Health Intervention) Related classifications to the main/ reference classification • ATC/DDD (The Anatomical Therapeutic chemical classification system with Defined Daily Doses) • ATCvet (The Anatomical Therapeutic Chemical Classification System for veterinary medicinal products) • ICECI (International Classification of External Causes
    [Show full text]
  • Using LOINC with SNOMED CT 3 April 2017
    Using LOINC with SNOMED CT 3 April 2017 Latest web browsable version: http://snomed.org/loinc SNOMED CT Document Library: http://snomed.org/doc 1. Using LOINC with SNOMED CT . 3 1 Introduction . 4 2 Short Introduction to SNOMED CT . 6 2.1 Features of SNOMED CT . 6 2.2 Benefits of SNOMED CT . 7 3 Short Introduction to LOINC . 9 3.1 Features of LOINC . 9 3.2 Benefits of LOINC . 13 4 Cooperative Work . 15 4.1 Cooperative Work Overview . 15 4.2 Release File Specifications . 16 4.2.1 LOINC Part map reference set . 16 4.2.2 LOINC Term to Expression Reference Set . 18 4.3 Benefits of Products of the Cooperative Work . 21 5 Guidance on Use of SNOMED CT and LOINC Together . 22 5.1 Use of SNOMED CT and/or LOINC in . 22 5.2 Practical Guidance on Uses of SNOMED CT and LOINC . 23 5.2.1 Guideline A - Vital Signs (Observation Names and Values) . 23 5.2.2 Guideline B - Laboratory Orders . 24 5.2.3 Guideline C - Laboratory Test Results (Observation Names and Values) . 26 5.2.4 Guideline D - Specimens . 30 5.2.5 Guideline E - Animal Species and Breeds . 32 5.2.6 Guideline F - Procedures (Laboratory Methods) . 33 5.2.7 Practical Uses of Part Maps and Expression Associations . 34 5.2 Terminology Scenarios - Summary . 40 6 References . 40 Using LOINC with SNOMED CT (3 April 2017) Using LOINC with SNOMED CT The Guide to Use of SNOMED CT and LOINC together provides advice on combined use of SNOMED CT and LOINC.
    [Show full text]
  • ICD-10 International Statistical Classification of Diseases and Related Health Problems
    ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision Volume 2 Instruction manual 2010 Edition WHO Library Cataloguing-in-Publication Data International statistical classification of diseases and related health problems. - 10th revision, edition 2010. 3 v. Contents: v. 1. Tabular list – v. 2. Instruction manual – v. 3. Alphabetical index. 1.Diseases - classification. 2.Classification. 3.Manuals. I.World Health Organization. II.ICD-10. ISBN 978 92 4 154834 2 (NLM classification: WB 15) © World Health Organization 2011 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press through the WHO web site (http://www.who.int/about/licensing/copyright_form). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.
    [Show full text]
  • Clinical Vocabularies for Global Real World Evidence (RWE) | Evidera
    Clinical Vocabularies for Global RWE Analysis Don O’Hara, MS Senior Research Associate, Real-World Evidence, Evidera Vernon F. Schabert, PhD Senior Research Scientist, Real-World Evidence, Evidera Introduction significant volume of real-world evidence (RWE) analyses continue to be conducted with data A repurposed from healthcare administrative Don O’Hara Vernon F. Schabert databases. The range of sources represented by those databases has grown in response to demand for richer description of patient health status and outcomes. information for improved quality and coordination Data availability, including the range of available data of care, often using standardized messaging systems sources, has grown unevenly across the globe in response such as Health Level 7 (HL7). These messages are to country-specific market and regulatory dynamics. only as good as the standardization of codes between Nonetheless, as demand globalizes for RWE insights from message senders and receivers, which motivates the databases, those demands increase pressure on analysts encoding of facts using common code sets. The second to find ways to bridge differences between local data is the increased availability of common data models to sources to achieve comparable insights across regions. standardize the extraction and analysis of these data for RWE and drug safety purposes. While common data One of the challenges in bridging differences across models make compromises on the structure of tables databases is the codes used to represent key clinical and fields extracted from healthcare systems such as facts. Historically, RWE database studies have leveraged electronic medical records (EMR) and billing systems, local code sets for cost-bearing healthcare services they can improve consistency and replicability of analyses such as drugs, procedures, and laboratory tests.
    [Show full text]
  • Non-Interventional (Ni) Study Report
    Apixaban B0661018 NON-INTERVENTIONAL STUDY REPORT FINAL, 20 May 2015 NON-INTERVENTIONAL (NI) STUDY REPORT PASS information Title Post-approval safety study (PASS) of the utilization pattern of apixaban in the Netherlands Protocol number B0661018 Version identifier of the final study report 1.0 Date of last version of the final study 20 May 2016 report EU Post Authorisation Study (PAS) ENCEPP/SDPP/5177 register number Active substance B01AF02 apixaban Medicinal product Eliquis -2016 15:22 y Product reference EU/1/11/691/001-015 Procedure number EMEA/H/C/002148 Marketing Authorisation Holder (MAH) Bristol-Myers Squibb/Pfizer EEIG roved On: 23-Ma Joint PASS No pp Research question and objectives This is a descriptive study using roved\A retrospectively collected data from pp electronic health record databases. The study describes the utilization pattern of apixaban in the Netherlands (01 Dec 2011 through 31 Dec 2014). The study aimed 1) to estimate the proportions of apixaban users who receive the drug for the approved indications at the time of the first apixaban dispensing and 2) to describe the characteristics of the patients who were prescribed apixaban for 090177e188105755\A PFIZER CONFIDENTIAL Page 1 Approved v 1.0 930102376 1.0 Apixaban B0661018 NON-INTERVENTIONAL STUDY REPORT FINAL, 20 May 2015 on-label and off-label indications. Country(-ies) of study The Netherlands Author Marketing Authorisation Holder(s) Marketing Authorisation Holder(s) Bristol-Myers Squibb/Pfizer EEIG -2016 15:22 y MAH contact person roved On: 23-Ma pp roved\A pp This document contains confidential information belonging to Pfizer.
    [Show full text]
  • Ministry of Labour, Health and Social Affairs of Georgia
    WWW.MOH.GOV.GE Ministry of Labour, Health and Social Affairs of Georgia Georgia Health Management Information System Strategy “Healthy Georgia, Connected to You” 2011 Table of Contents Executive Summary . 5 Goals and Objectives. 6 Governance. 7 Operational.Aspects. 9 HMIS Standards. .10 Message.Standards. .10 Vocabulary.Standards.for.Medical.Care. .11 Diagnosis.-.ICD.10,.Medcin. .12 Treatments.-.CPT. .13 Drugs.–RXNorm,.Multum,.Medispan,.First.Data.Bank. .13 Lab.–.LOINC,.SNOMED . .13 Administrative.Standards . .13 Citizens/Patients. .14 Provider.Credentialing,.Licensing.and.Unique.Identifiers. .14 National.Drug.Database . .14 Health.Data.Dictionary . .14 HMIS.Key.Indicators.and.Metrics. .15 HMIS.Core.Data.Sets. .15 HMIS Functionality . .16 Overview. .16 What.is.not.an.HMIS.component . .19 Software.Acquisition.versus.Development. .19 Selective.review.of.relevant.systems.that.are.already.available.in.Georgia . .23 Hesperus . .23 Vaccinations.system . .23 Electronic.registration.for.births.and.deaths.system. .23 TB.system,.AIDS.system,. .23 Surveillance.system.(DETRA).–.Infectious.Disease. .24 EU.project.for.MD’s.in.villages.to.be.equipped.with.400.PC’s . .24 SIMS. .24 Electronic Medical Record (EMR) . .25 Personal.and.Health.Information. .26 Results.Management. .26 Order.Management. .26 Decision.Support. .26 Reporting . .26 Electronic.Communication.and.Connectivity. .26 Patient.Support . .27 Administrative.Processes . .28 3 Financial Information System Functionality. .29 Georgian Health Data Repository (GHDR) . .32 Populating.the.Georgian.Health.Data.Repository.(GHDR) . .33 Extract,.Transform.Load. .34 Data.Domains.(Categories). .34 Data.Analysis.and.Presentation. .35 Reporting . .35 Dashboards . .36 GHDR.Uses. .36 Georgian.Healthcare.Statistics. .36 Monitoring.Healthcare.Costs. .36 Public.Health.Surveillance .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. ...36 Decision.Support:..Improving.Patient.Care .
    [Show full text]
  • Ata Lements for Mergency Epartment Ystems
    D ata E lements for E mergency D epartment S ystems Release 1.0 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES CDCCENTERS FOR DISEASE CONTROL AND PREVENTION D ata E lements for E mergency D epartment S ystems Release 1.0 National Center for Injury Prevention and Control Atlanta, Georgia 1997 Data Elements for Emergency Department Systems, Release 1.0 (DEEDS) is the result of contributions by participants in the National Workshop on Emergency Department Data, held January 23-25, 1996, in Atlanta, Georgia, subsequent review and comment by individuals who read Release 1.0 in draft form, and finalization by a multidisciplinary writing committee. DEEDS is a set of recommendations published by the National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention: Centers for Disease Control and Prevention David Satcher, MD, PhD, Director National Center for Injury Prevention and Control Mark L. Rosenberg, MD, MPP, Director Division of Acute Care, Rehabilitation Research, and Disability Prevention Richard J. Waxweiler, PhD, Director Acute Care Team Daniel A. Pollock, MD, Leader Production services were provided by the staff of the Office of Communication Resources, National Center for Injury Prevention and Control, and the Management Analysis and Services Office: Editing Valerie R. Johnson Cover Design and Layout Barbara B. Lord Use of trade names is for identification only and does not constitute endorsement by the U.S. Department of Health and Human Services. This document and subsequent revisions can be found at the National Center for Injury Prevention and Control Web site: http://www.cdc.gov/ncipc/pub-res/deedspage.htm Suggested Citation: National Center for Injury Prevention and Control.
    [Show full text]
  • (Child Core Set) Technical Specifications and Reso
    Core Set of Children's Health Care Quality Measures for Medicaid and CHIP (Child Core Set) Technical Specifications and Resource Manual for Federal Fiscal Year 2019 Reporting February 2019 Center for Medicaid and CHIP Services Centers for Medicare & Medicaid Services This page left blank for double-sided copying ii ACKNOWLEDGMENTS For Proprietary Codes: CPT® codes copyright 2018 American Medical Association. All rights reserved. CPT is a trademark of the American Medical Association. No fee schedules, basic units, relative values or related listings are included in CPT. The AMA assumes no liability for the data contained herein. Applicable FARS/DFARS restrictions apply to government use. SNOMED CLINICAL TERMS (SNOMED CT®) copyright 2004-2018 The International Health Terminology Standards Development Organisation. All Rights Reserved. The International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) is published by the World Health Organization (WHO). ICD-9-CM is an official Health Insurance Portability and Accountability Act standard. The International Classification of Diseases, 9th Revision, Procedure Coding System (ICD-9-PCS) is published by the World Health Organization (WHO). ICD-9-PCS is an official Health Insurance Portability and Accountability Act standard. The International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) is published by the World Health Organization (WHO). ICD-10-CM is an official Health Insurance Portability and Accountability Act standard. The International Classification of Diseases, 10th Revision, Procedure Coding System (ICD-10-PCS) is published by the World Health Organization (WHO). ICD-10-PCS is an official Health Insurance Portability and Accountability Act standard. This material contains content from LOINC® (http://loinc.org).
    [Show full text]